Digital scoring of EpCAM and slug expression as prognostic markers in head and neck squamous cell carcinomas. Issue 4 (29th December 2020)
- Record Type:
- Journal Article
- Title:
- Digital scoring of EpCAM and slug expression as prognostic markers in head and neck squamous cell carcinomas. Issue 4 (29th December 2020)
- Main Title:
- Digital scoring of EpCAM and slug expression as prognostic markers in head and neck squamous cell carcinomas
- Authors:
- Schinke, Henrik
Heider, Theresa
Herkommer, Timm
Simon, Florian
Blancke Soares, Alexandra
Kranz, Gisela
Samaga, Daniel
Dajka, Laura
Feuchtinger, Annette
Walch, Axel
Valeanu, Laura
Walz, Christoph
Kirchner, Thomas
Canis, Martin
Baumeister, Philipp
Belka, Claus
Maihöfer, Cornelius
Marschner, Sebastian
Pflugradt, Ulrike
Ganswindt, Ute
Hess, Julia
Zitzelsberger, Horst
Gires, Olivier - Abstract:
- Abstract : Head and neck squamous cell carcinomas (HNSCCs) have poor clinical outcome owing to therapy resistance and frequent recurrences that are among others attributable to tumor cells in partial epithelial‐to‐mesenchymal transition (pEMT). We compared side‐by‐side software‐based and visual quantification of immunohistochemistry (IHC) staining of epithelial marker EpCAM and EMT regulator Slug in n = 102 primary HNSCC to assess optimal analysis protocols. IHC scores incorporated expression levels and percentages of positive cells. Digital and visual evaluation of membrane‐associated EpCAM yielded correlating scorings, whereas visual evaluation of nuclear Slug resulted in significantly higher overall scores. Multivariable Cox proportional hazard analysis defined the median EpCAM expression levels resulting from visual quantification as an independent prognostic factor of overall survival. Slug expression levels resulting from digital quantification were an independent prognostic factor of recurrence‐free survival, locoregional recurrence‐free survival, and disease‐specific survival. Hence, we propose to use visual assessment for the membrane‐associated EpCAM protein, whereas nuclear protein Slug assessment was more accurate following digital measurement. Abstract : Epithelial‐to‐mesenchymal transition (EMT) impacts on the clinical outcome of head and neck squamous cell carcinomas (HNSCC). Here, we compared visual and digital scoring of epithelial marker EpCAM and EMTAbstract : Head and neck squamous cell carcinomas (HNSCCs) have poor clinical outcome owing to therapy resistance and frequent recurrences that are among others attributable to tumor cells in partial epithelial‐to‐mesenchymal transition (pEMT). We compared side‐by‐side software‐based and visual quantification of immunohistochemistry (IHC) staining of epithelial marker EpCAM and EMT regulator Slug in n = 102 primary HNSCC to assess optimal analysis protocols. IHC scores incorporated expression levels and percentages of positive cells. Digital and visual evaluation of membrane‐associated EpCAM yielded correlating scorings, whereas visual evaluation of nuclear Slug resulted in significantly higher overall scores. Multivariable Cox proportional hazard analysis defined the median EpCAM expression levels resulting from visual quantification as an independent prognostic factor of overall survival. Slug expression levels resulting from digital quantification were an independent prognostic factor of recurrence‐free survival, locoregional recurrence‐free survival, and disease‐specific survival. Hence, we propose to use visual assessment for the membrane‐associated EpCAM protein, whereas nuclear protein Slug assessment was more accurate following digital measurement. Abstract : Epithelial‐to‐mesenchymal transition (EMT) impacts on the clinical outcome of head and neck squamous cell carcinomas (HNSCC). Here, we compared visual and digital scoring of epithelial marker EpCAM and EMT marker Slug in HNSCC for routine quantification of EMT. We propose to use visual assessment for membrane‐associated EpCAM, whereas nuclear protein Slug assessment was more accurate following digital measurement. … (more)
- Is Part Of:
- Molecular oncology. Volume 15:Issue 4(2021)
- Journal:
- Molecular oncology
- Issue:
- Volume 15:Issue 4(2021)
- Issue Display:
- Volume 15, Issue 4 (2021)
- Year:
- 2021
- Volume:
- 15
- Issue:
- 4
- Issue Sort Value:
- 2021-0015-0004-0000
- Page Start:
- 1040
- Page End:
- 1053
- Publication Date:
- 2020-12-29
- Subjects:
- antigen scoring -- EMT -- EpCAM -- HNSCC -- Slug
Cancer -- Molecular aspects -- Periodicals
616.994005 - Journal URLs:
- http://www.journals.elsevier.com/molecular-oncology/ ↗
http://febs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)1878-0261/issues/ ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1002/1878-0261.12886 ↗
- Languages:
- English
- ISSNs:
- 1574-7891
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5900.817993
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 16175.xml